Lack of FDA news has had an effect on the share price but I feel it was the poor sales in the last quarter which concerned investors.Cst more or less signaled sales were increasing with their graph release only to produce a $2.5 mill result.In reality selling was smart as long as you got back in.For me I just sit tight and add when I can wrestle the cheque book off my better half.
Regards,
